Mycocycle

Market position

Mycocycle positions itself in the waste-to-value and circular-bioeconomy segment, targeting hard-to-recycle construction and demolition materials. Company materials cite a construction industry total addressable market of $14.4 trillion by 2030, a global building materials industry above $1 trillion, and a global mycelium market expected to reach $3.84 billion by 2026. Investor Closed Loop Partners characterized the company as enabling more circular and local processing and production technologies for materials in the built environment. [4][6]

The company differentiates on a fungal, biology-based treatment that both detoxifies hard-to-recycle waste and converts it into a saleable low-carbon raw material, rather than only diverting or disposing of waste. Additional stated differentiators include a short treatment cycle of roughly two weeks, up to 98% average toxicity reduction, decentralized on-site treatment via the MYCOntainer, cost parity with incineration for some waste types such as carpet, and patent-pending process and product IP. [0][4][6]

Technology

The core technology is a patent-pending mycoremediation process that blends lab-cultivated fungi with ground built-environment waste and incubates it under controlled conditions for 7-14 days, after which the material is harvested and processed into raw materials. The mechanism combines biosorption, bioconversion and biodegradation to neutralize toxic constituents derived from plastics and petrochemicals, with reported toxicity reduction of up to 98% on average. Delivery formats include in situ, ex situ and micro-process site treatment, plus a first-generation decentralized, climate-controlled treatment container branded MYCOntainer. Product outputs are MycoFILL, MycoFIBER and MycoFOAM. [0][4][6]

Go-to-market

Mycocycle engages customers through paid pilots and partnerships with waste material providers, contractors and building owners, treating waste at the point of generation on customer construction and demolition sites. It has also used accelerator and institutional programs for visibility and validation, including Startup Chicago, the World Economic Forum/Accenture Circulars Accelerator, Argonne National Laboratory's Chain Reaction Innovations fellowship, and membership in the U.S. Department of Energy's REMADE Institute. Following its 2024 seed extension the company said it would deepen relationships with existing waste-material partners, expand its waste-to-value chain, and hire across marketing, technology and operations. [3][4][5][6]

Waste management, recycling and manufacturing companies; building owners, contractors and developers focused on Scope 3 emission reduction and construction-waste diversion; and building-products manufacturers seeking biobased fillers, fibers and foams. Named partners and pilot customers include META and Lendlease. [3][4][6]

Geography

Headquartered in Bolingbrook, Illinois, with operations and ecosystem ties in the Chicago area; press releases were issued from Chicago. Market focus is described as national (U.S.) waste and building materials sectors. [0][3][4][6]

History

Press materials state the company was founded in 2018. It was named to the inaugural class of Startup Chicago in January 2021, joined the U.S. Department of Energy's REMADE Institute in June 2021, was named a finalist for 1871's Momentum Award in the Industry Disrupter category in August 2021, and had a research partnership awarded REMADE Institute funding in December 2021 for a 24-month life-cycle-analysis project on healthcare-sector metalware and plastics. In 2022 it participated in the World Economic Forum/Accenture Circulars Accelerator as one of 17 companies worldwide, founder and CEO Joanne Rodriguez was selected for Argonne National Laboratory's Chain Reaction Innovations Cohort 6, and the company joined other Chicago Innovation Awards winners in ringing the Nasdaq closing bell in July 2022. It added two senior leaders in December 2022 and joined the Chicago H1-B Connect coalition in January 2023. A $2.2 million seed round was announced in May 2023 and a $3.6 million seed extension in May 2024. [3][4][5][6]

Risks & controversies

Process and product protection is described as patent-pending rather than granted. Commercial scale remains early: reported throughput was 12,000 pounds treated cumulatively as of May 2023 and capacity of 40 metric tons per month as of May 2024, and validation of the reuse of the biobased byproduct was still a stated objective of the 2023 funding. [0][4][6]